Testing effectiveness (Phase 2)Study completedNCT00003425
What this trial is testing
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
University of Kentucky 25